Table 2.
Predefined outcome of included studies
| Study/year | GI bleeding | Mortality | Pneumonia | CDI | VAP | Duration of MV | Length of ICU stay | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SUP | Control | SUP | Control | SUP | Control | SUP | Control | SUP | Control | SUP | Control | SUP | Control | |
| Alhazzani 2017 [18] | 4/49 | 3/42 | 17/49 | 13/42 | 10/49 | 6/42 | 2/49 | 1/42 | 10/49 | 6/42 | 9 (5–17) | 6.5 (4–14) | 12 (8–23) | 8.5 (6–18) |
| El-Kersh 2017 [29] | 1/55 | 1/47 | 7/55 | 8/47 | - | - | 1/55 | 3/47 | 4 (2.2–7) | 5 (3–8) | 6 (4–6.9) | 7 (3.5–11.5) | ||
| Selvanderan 2016 [27] | 3/106 | 6/108 | 30/106 | 25/108 | 12/106 | 8/108 | 1/106 | 0/108 | 12/106 | 8/108 | 21 (0–25) | 21 (4–25) | 6 (3–11) | 7 (4–14) |
| Lin 2016 [28] | 0/60 | 6/60 | 2/60 | 0/60 | 4/60 | 6/60 | - | - | 4/60 | 6/60 | - | - | - | - |
| Ben-menachem 1994 [22] | 10/200 | 6/200 | 45/200 | 19/100 | 25/200 | 6/100 | - | - | 7.3 (8.9)/8.1 (1.1) | 7.9 (9.6) | 3 (2–8.5)/4 (2–9) | 3 (2–8) | ||
| Apte 1992 [21] | 5/16 | 6/18 | 11/16 | 7/18 | 11/16 | 7/18 | - | - | - | - | - | - | ||
| Van den Berg 1985 [23] | 5/14 | 1/14 | - | - | - | - | - | - | - | - | - | - | ||
CDI Clostridium difficile infection, GI gastrointestinal, MV mechanical ventilation, SUP stress ulcer prophylaxis, VAP ventilator associated pneumonia
Continuous data are given as median (25th–75th percentile), mean (standard deviation, SD)